MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Medpace Holdings Inc

Chiusa

SettoreSettore sanitario

322.02 -0.57

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

318.54

Massimo

327.57

Metriche Chiave

By Trading Economics

Entrata

-2.4M

115M

Vendite

22M

559M

P/E

Media del settore

23.977

40.527

EPS

3.67

Margine di Profitto

20.516

Dipendenti

5,900

EBITDA

-4.9M

120M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-3.12% downside

Dividendi

By Dow Jones

Utili prossimi

21 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

65M

9B

Apertura precedente

322.59

Chiusura precedente

322.02

Notizie sul Sentiment di mercato

By Acuity

50%

50%

157 / 375 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Medpace Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

3 lug 2025, 23:45 UTC

Acquisizioni, Fusioni, Takeovers

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3 lug 2025, 23:42 UTC

Discorsi di Mercato

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3 lug 2025, 23:41 UTC

Discorsi di Mercato

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3 lug 2025, 23:41 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

3 lug 2025, 23:15 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3 lug 2025, 22:59 UTC

Discorsi di Mercato

Uranium Market About to Enter Lull -- Market Talk

3 lug 2025, 22:58 UTC

Discorsi di Mercato

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3 lug 2025, 22:47 UTC

Discorsi di Mercato

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3 lug 2025, 22:21 UTC

Utili

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3 lug 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

3 lug 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

3 lug 2025, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

3 lug 2025, 20:41 UTC

Discorsi di Mercato

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3 lug 2025, 20:41 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

3 lug 2025, 19:28 UTC

Discorsi di Mercato

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3 lug 2025, 19:03 UTC

Discorsi di Mercato

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3 lug 2025, 18:34 UTC

Discorsi di Mercato

Gold Has Winning Week, But Down Day -- Market Talk

3 lug 2025, 18:18 UTC

Discorsi di Mercato

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3 lug 2025, 18:06 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

3 lug 2025, 18:06 UTC

Discorsi di Mercato

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3 lug 2025, 17:27 UTC

Discorsi di Mercato

U.S. Oil Rig Count Continues to Slide -- Market Talk

3 lug 2025, 16:55 UTC

Utili

Travel Stocks Could Offer Investors a Glorious -2-

3 lug 2025, 16:55 UTC

Utili

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3 lug 2025, 16:20 UTC

Discorsi di Mercato

Correction to Health Care Roundup: Market Talk

3 lug 2025, 16:15 UTC

Discorsi di Mercato

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3 lug 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

3 lug 2025, 16:05 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

3 lug 2025, 16:05 UTC

Discorsi di Mercato

Gold Futures Fall Following Jobs Report -- Market Talk

3 lug 2025, 15:47 UTC

Utili

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3 lug 2025, 15:36 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Confronto tra pari

Modifica del prezzo

Medpace Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

-3.12% in calo

Previsioni per 12 mesi

Media 315.86 USD  -3.12%

Alto 355 USD

Basso 285 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Medpace Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

8 ratings

1

Acquista

7

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

300 / 302.88Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

157 / 375 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.